244 related articles for article (PubMed ID: 23067195)
1. [Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and health related quality of life: results from the SHIFT substudies].
Vítovec J; Spinarová L; Spinar J
Vnitr Lek; 2012; 58(7-8):612-17. PubMed ID: 23067195
[TBL] [Abstract][Full Text] [Related]
2. Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction.
Perry CM
Am J Cardiovasc Drugs; 2012 Dec; 12(6):415-26. PubMed ID: 23181944
[TBL] [Abstract][Full Text] [Related]
3. Effect of ivabradine on left ventricular remodelling after reperfused myocardial infarction: A pilot study.
Gerbaud E; Montaudon M; Chasseriaud W; Gilbert S; Cochet H; Pucheu Y; Horovitz A; Bonnet J; Douard H; Coste P
Arch Cardiovasc Dis; 2014 Jan; 107(1):33-41. PubMed ID: 24440004
[TBL] [Abstract][Full Text] [Related]
4. Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy.
Tardif JC; O'Meara E; Komajda M; Böhm M; Borer JS; Ford I; Tavazzi L; Swedberg K;
Eur Heart J; 2011 Oct; 32(20):2507-15. PubMed ID: 21875858
[TBL] [Abstract][Full Text] [Related]
5. Ivabradine for the treatment of chronic heart failure.
Henri C; O'Meara E; De Denus S; Elzir L; Tardif JC
Expert Rev Cardiovasc Ther; 2016; 14(5):553-61. PubMed ID: 26967048
[TBL] [Abstract][Full Text] [Related]
6. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
Mulder P; Barbier S; Chagraoui A; Richard V; Henry JP; Lallemand F; Renet S; Lerebours G; Mahlberg-Gaudin F; Thuillez C
Circulation; 2004 Apr; 109(13):1674-9. PubMed ID: 14981003
[TBL] [Abstract][Full Text] [Related]
7. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.
Swedberg K; Komajda M; Böhm M; Borer JS; Ford I; Dubost-Brama A; Lerebours G; Tavazzi L;
Lancet; 2010 Sep; 376(9744):875-85. PubMed ID: 20801500
[TBL] [Abstract][Full Text] [Related]
8. Ivabradine: Heart Failure and Beyond.
Chaudhary R; Garg J; Krishnamoorthy P; Shah N; Lanier G; Martinez MW; Freudenberger R
J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):335-43. PubMed ID: 26721645
[TBL] [Abstract][Full Text] [Related]
9. Heart rate reduction in heart failure: ivabradine or beta blockers?
Guglin M
Heart Fail Rev; 2013 Jul; 18(4):517-28. PubMed ID: 22972475
[TBL] [Abstract][Full Text] [Related]
10. Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study.
Swedberg K; Komajda M; Böhm M; Borer J; Robertson M; Tavazzi L; Ford I;
J Am Coll Cardiol; 2012 May; 59(22):1938-45. PubMed ID: 22617188
[TBL] [Abstract][Full Text] [Related]
11. Ivabradine in Management of Heart Failure: a Critical Appraisal.
Orasanu G; Al-Kindi SG; Oliveira GH
Curr Heart Fail Rep; 2016 Feb; 13(1):60-9. PubMed ID: 26797824
[TBL] [Abstract][Full Text] [Related]
12. Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial.
Kosmala W; Holland DJ; Rojek A; Wright L; Przewlocka-Kosmala M; Marwick TH
J Am Coll Cardiol; 2013 Oct; 62(15):1330-8. PubMed ID: 23916925
[TBL] [Abstract][Full Text] [Related]
13. Effect of Chronic Heart Rate Reduction by I(f) Current Inhibitor Ivabradine on Left Ventricular Remodeling and Systolic Performance in Middle-Aged Rats With Postmyocardial Infarction Heart Failure.
Dedkov EI; Bogatyryov Y; McCooey DS; Christensen LP; Weiss RM; Tomanek RJ
J Cardiovasc Pharmacol Ther; 2015 May; 20(3):299-312. PubMed ID: 25287895
[TBL] [Abstract][Full Text] [Related]
14. Prescribing patterns to optimize heart rate: analysis of 1,000 consecutive outpatient appointments to a single heart failure clinic over a 6-month period.
Dierckx R; Cleland JG; Parsons S; Putzu P; Pellicori P; Dicken B; Boyalla V; Clark AL
JACC Heart Fail; 2015 Mar; 3(3):224-30. PubMed ID: 25650369
[TBL] [Abstract][Full Text] [Related]
15. Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL.
Ceconi C; Freedman SB; Tardif JC; Hildebrandt P; McDonagh T; Gueret P; Parrinello G; Robertson M; Steg PG; Tendera M; Ford I; Fox K; Ferrari R;
Int J Cardiol; 2011 Feb; 146(3):408-14. PubMed ID: 21112101
[TBL] [Abstract][Full Text] [Related]
16. Advances in the management of heart failure: the role of ivabradine.
Müller-Werdan U; Stöckl G; Werdan K
Vasc Health Risk Manag; 2016; 12():453-470. PubMed ID: 27895488
[TBL] [Abstract][Full Text] [Related]
17. Update on ivabradine for heart failure.
Borer JS; Tavazzi L
Trends Cardiovasc Med; 2016 Jul; 26(5):444-9. PubMed ID: 26934996
[TBL] [Abstract][Full Text] [Related]
18. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.
Abdel-Salam Z; Rayan M; Saleh A; Abdel-Barr MG; Hussain M; Nammas W
Cardiol J; 2015; 22(2):227-32. PubMed ID: 25179314
[TBL] [Abstract][Full Text] [Related]
19. Cardiac and Hemodynamic Benefits: Mode of Action of Ivabradine in Heart Failure.
Pereira-Barretto AC
Adv Ther; 2015 Oct; 32(10):906-19. PubMed ID: 26521191
[TBL] [Abstract][Full Text] [Related]
20. Ivabradine on aortic stiffness in patients with heart failure.
Nar G; Inci S; Aksan G; Demirelli S; Soylu K; Yuksel S; Gulel O; Icli A
J Investig Med; 2015 Apr; 63(4):620-5. PubMed ID: 25706659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]